Balance, a technology platform providing comprehensive obesity treatment, has closed a €3 million Seed funding round that will enable the company to accelerate its growth across Spain, strengthen its technology and clinical capabilities, and prepare for a Series A financing round planned for 2027. Following the transaction, the company has reached a €15 million valuation.
The round was led by Shilling VC, with participation from JME, Atresmedia Capital and a group of business angels. The financing brings the total amount raised by Balance to more than €4 million since its launch, following an earlier pre-Seed round led by JME and Antai Ventures.
The transaction comes at a time when obesity has become one of Spain's most pressing public health challenges. According to available data, the condition affects one in four adults and is associated with more than 200 diseases, including cardiovascular disease, type 2 diabetes and metabolic disorders. Increasingly, obesity is being recognised as a chronic disease requiring a comprehensive, long-term approach to treatment.
With the new funding, Balance will strengthen its technology, clinical and operations teams, accelerate patient acquisition and retention, and continue enhancing its platform to scale its care model. The company also plans to consolidate its direct-to-consumer (B2C) business while expanding into the B2B segment through strategic partnerships and commercial agreements.
Jesús Rebollo, Co-founder and CEO of Balance, said: "This funding round allows us to accelerate from a position of greater strength. It is not just about growing faster, but about scaling a model that has already demonstrated there is a more continuous, coordinated and personalised way to support people living with obesity. Our goal is to establish Balance as the leading obesity care platform in Spain while preparing the company for international expansion."
Balance has developed a technology platform that connects people living with obesity with an independent multidisciplinary team of physicians, nutritionists, exercise specialists and psychologists. This forms the basis of the Balance Method®, a comprehensive programme that treats obesity as a chronic disease through four core pillars: medical care, nutrition, physical activity and emotional support, all integrated through the company's digital platform.
The company's business model is primarily based on direct-to-consumer (B2C) subscriptions, offering patients continuous, coordinated support from healthcare professionals. Unlike the traditional episodic care model, Balance aims to provide ongoing follow-up and closer collaboration between specialists, improving treatment outcomes and supporting long-term behavioural change.
"Balance was created to address a structural limitation in the traditional treatment of obesity: the lack of continuity between appointments and the disconnect between healthcare professionals treating a disease driven by biological, genetic, hormonal, environmental and social factors. Our platform enables medical care, nutrition, exercise and behavioural support to work together in a coordinated way, paving the way for a more personalised and sustainable long-term treatment," said Javier García Palacios, Co-founder and Chief Strategic & Clinic Excellence Officer of Balance.
cloud technology axon
The private investors joining the initiative include Danske Bank from ...
